Literature DB >> 23535010

Clinical and molecular spectrum of renal malformations in Kabuki syndrome.

Jean-Benoît Courcet1, Laurence Faivre, Caroline Michot, Antoine Burguet, Stéphanie Perez-Martin, Eudeline Alix, Jeanne Amiel, Clarisse Baumann, Marie-Pierre Cordier, Valérie Cormier-Daire, Marie Ange Delrue, Brigitte Gilbert-Dussardier, Alice Goldenberg, Marie-Line Jacquemont, Aurélia Jaquette, Honorine Kayirangwa, Didier Lacombe, Martine Le Merrer, Annick Toutain, Sylvie Odent, Anne Moncla, Anna Pelet, Nicole Philip, Lucille Pinson, Sylvain Poisson, Le Quan Sang Kim-Han, Joelle Roume, Elodie Sanchez, Marjolaine Willems, Marianne Till, Catherine Vincent-Delorme, Christiane Mousson, Sandrine Vinault, Christine Binquet, Frédéric Huet, Pierre Sarda, Rémi Salomon, Stanislas Lyonnet, Damien Sanlaville, David Geneviève.   

Abstract

OBJECTIVE: To determine the frequency and types of renal malformations, and to evaluate renal function in a cohort of patients with Kabuki syndrome (KS). STUDY
DESIGN: Renal ultrasound scans and plasma creatinine measurements were collected from a French cohort of 94 patients with genotyped KS. Renal function was evaluated based on the estimated glomerular filtration rate. A genotype-phenotype study was conducted for renal and urinary tract malformations.
RESULTS: Renal malformations were present in 22% of cases, and urinary tract anomalies were present in 15%. Renal malformations were observed in 28% of the MLL2 mutation-positive group and in 0% of the MLL2 mutation-negative group (P = .015). No correlation was found between the presence or absence of renal or urinary tract malformations and the location or type of MLL2 mutation. Renal function was normal except for 1 patient with a MLL2 mutation diagnosed in the first days of life and severe renal disease due to unilateral renal agenesia and controlateral severe hypoplasia that progressed to the terminal stage at age 2 years.
CONCLUSION: Our study emphasizes the need for ultrasound and renal function screening in children diagnosed with KS.
Copyright © 2013 Mosby, Inc. All rights reserved.

Entities:  

Keywords:  Estimated glomerular filtration rate; KS; Kabuki syndrome; US; Ultrasound; eGFR

Mesh:

Substances:

Year:  2013        PMID: 23535010     DOI: 10.1016/j.jpeds.2013.02.032

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  6 in total

1.  A ketogenic diet rescues hippocampal memory defects in a mouse model of Kabuki syndrome.

Authors:  Joel S Benjamin; Genay O Pilarowski; Giovanni A Carosso; Li Zhang; David L Huso; Loyal A Goff; Hilary J Vernon; Kasper D Hansen; Hans T Bjornsson
Journal:  Proc Natl Acad Sci U S A       Date:  2016-12-20       Impact factor: 11.205

Review 2.  Kabuki syndrome: a Chinese case series and systematic review of the spectrum of mutations.

Authors:  Shuang Liu; Xiafei Hong; Cheng Shen; Quan Shi; Jian Wang; Feng Xiong; Zhengqing Qiu
Journal:  BMC Med Genet       Date:  2015-04-21       Impact factor: 2.103

3.  Orofacial features and medical profile of eight individuals with Kabuki syndrome.

Authors:  N Silva-Andrade; K López-Ortega; M Gallottini
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2019-09-01

4.  Singleton exome sequencing of 90 fetuses with ultrasound anomalies revealing novel disease-causing variants and genotype-phenotype correlations.

Authors:  Mateja Smogavec; Maria Gerykova Bujalkova; Reinhard Lehner; Jürgen Neesen; Jana Behunova; Gülen Yerlikaya-Schatten; Theresa Reischer; Reinhard Altmann; Denisa Weis; Hans-Christoph Duba; Franco Laccone
Journal:  Eur J Hum Genet       Date:  2022-01-01       Impact factor: 4.246

5.  De Novo KMT2D Heterozygous Frameshift Deletion in a Newborn with a Congenital Heart Anomaly.

Authors:  Š Stangler Herodež; N Marčun Varda; Kokalj Vokač N; D Krgović
Journal:  Balkan J Med Genet       Date:  2020-08-26       Impact factor: 0.519

Review 6.  Kabuki Syndrome-Clinical Review with Molecular Aspects.

Authors:  Snir Boniel; Krystyna Szymańska; Robert Śmigiel; Krzysztof Szczałuba
Journal:  Genes (Basel)       Date:  2021-03-25       Impact factor: 4.096

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.